Literature DB >> 30304705

Chemical biomarkers of epileptogenesis and ictogenesis in experimental epilepsy.

Hiram Luna-Munguia1, Alexander G Zestos2, Stephen V Gliske3, Robert T Kennedy4, William C Stacey5.   

Abstract

Epilepsy produces chronic chemical changes induced by altered cellular structures, and acute ones produced by conditions leading into individual seizures. Here, we aim to quantify 24 molecules simultaneously at baseline and during periods of lowered seizure threshold in rats. Using serial hippocampal microdialysis collections starting two weeks after the pilocarpine-induced status epilepticus, we evaluated how this chronic epilepsy model affects molecule levels and their interactions. Then, we quantified the changes occurring when the brain moves into a pro-seizure state using a novel model of physiological ictogenesis. Compared with controls, pilocarpine animals had significantly decreased baseline levels of adenosine, homovanillic acid, and serotonin, but significantly increased levels of choline, glutamate, phenylalanine, and tyrosine. Step-wise linear regression identified that choline, homovanillic acid, adenosine, and serotonin are the most important features to characterize the difference in the extracellular milieu between pilocarpine and control animals. When increasing the hippocampal seizure risk, the concentrations of normetanephrine, serine, aspartate, and 5-hydroxyindoleacetic acid were the most prominent; however, there were no specific, consistent changes prior to individual seizures.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epilepsy; Hippocampus; Ictogenesis; Microdialysis; Nucleus reuniens; Pilocarpine

Mesh:

Substances:

Year:  2018        PMID: 30304705      PMCID: PMC6242767          DOI: 10.1016/j.nbd.2018.10.005

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  51 in total

Review 1.  Brain microdialysis and its applications in experimental neurochemistry.

Authors:  Elmira Anderzhanova; Carsten T Wotjak
Journal:  Cell Tissue Res       Date:  2013-10       Impact factor: 5.249

Review 2.  Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma.

Authors:  Wolfgang Löscher; Dieter Schmidt
Journal:  Epilepsia       Date:  2011-03-22       Impact factor: 5.864

Review 3.  Molecular and cellular mechanisms of excitotoxic neuronal death.

Authors:  Yan Wang; Zheng-Hong Qin
Journal:  Apoptosis       Date:  2010-11       Impact factor: 4.677

Review 4.  The neurobiology of temporal lobe epilepsy: too much information, not enough knowledge.

Authors:  Robert S Sloviter
Journal:  C R Biol       Date:  2005-02       Impact factor: 1.583

Review 5.  The relevance of kindling for human epilepsy.

Authors:  Edward Bertram
Journal:  Epilepsia       Date:  2007       Impact factor: 5.864

6.  2014 Epilepsy Benchmarks Area III: Improve Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects.

Authors:  Dennis Dlugos; Greg Worrell; Kathryn Davis; William Stacey; Jerzy Szaflarski; Andres Kanner; Sridhar Sunderam; Mike Rogawski; Patrice Jackson-Ayotunde; Tobias Loddenkemper; Beate Diehl; Brandy Fureman; Ray Dingledine
Journal:  Epilepsy Curr       Date:  2016 May-Jun       Impact factor: 7.500

Review 7.  Adenosine as a neuromodulator in neurological diseases.

Authors:  Detlev Boison
Journal:  Curr Opin Pharmacol       Date:  2007-10-17       Impact factor: 5.547

8.  Decreased dopamine level in the epileptic focus.

Authors:  A Mori; M Hiramatsu; S Namba; A Nishimoto; T Ohmoto; Y Mayanagi; T Asakura
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1987-05

9.  Adenosine: a potential mediator of seizure arrest and postictal refractoriness.

Authors:  M J During; D D Spencer
Journal:  Ann Neurol       Date:  1992-11       Impact factor: 10.422

10.  Deficits in brain serotonin synthesis in a genetic mouse model of phenylketonuria.

Authors:  Tiziana Pascucci; Rossella Ventura; Stefano Puglisi-Allegra; Simona Cabib
Journal:  Neuroreport       Date:  2002-12-20       Impact factor: 1.837

View more
  7 in total

Review 1.  Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies.

Authors:  Detlev Boison; Jong M Rho
Journal:  Neuropharmacology       Date:  2019-08-13       Impact factor: 5.250

2.  Polymer-Modified Carbon Fiber Microelectrodes for Neurochemical Detection of Dopamine and Metabolites.

Authors:  P M Wonnenberg; A G Zestos
Journal:  ECS Trans       Date:  2020-05

Review 3.  Serotonin and sudden unexpected death in epilepsy.

Authors:  Alexandra N Petrucci; Katelyn G Joyal; Benton S Purnell; Gordon F Buchanan
Journal:  Exp Neurol       Date:  2019-12-19       Impact factor: 5.330

4.  (-)-Epigallocatechin-3-Gallate Protects Against Lithium-Pilocarpine-Induced Epilepsy by Inhibiting the Toll-Like Receptor 4 (TLR4)/Nuclear Factor-κB (NF-κB) Signaling Pathway.

Authors:  Zhenzhen Qu; Lijing Jia; Tao Xie; Junli Zhen; Peipei Si; Zhiqiang Cui; Yan Xue; Can Sun; Weiping Wang
Journal:  Med Sci Monit       Date:  2019-03-07

5.  Timed Electrodeposition of PEDOT:Nafion onto Carbon Fiber-Microelectrodes Enhances Dopamine Detection in Zebrafish Retina.

Authors:  Whirang Cho; Favian Liu; Aaron Hendrix; Brazil McCray; Thomas Asrat; Victoria Connaughton; Alexander G Zestos
Journal:  J Electrochem Soc       Date:  2020-07-14       Impact factor: 4.316

6.  Altered plasma glutamate and glutamine levels in patients with drug-resistant and drug-responsive symptomatic focal epilepsy.

Authors:  Wei Wang; Yanchuan Wu; Xiaoling Li; Lin Li; Ke Sun; Suying Yan
Journal:  Neurosciences (Riyadh)       Date:  2021-10       Impact factor: 0.735

Review 7.  Insights into Potential Targets for Therapeutic Intervention in Epilepsy.

Authors:  Cecilia Zavala-Tecuapetla; Manola Cuellar-Herrera; Hiram Luna-Munguia
Journal:  Int J Mol Sci       Date:  2020-11-13       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.